Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
BioSpace
Wed, 03/13/24 - 10:39 am
Ricoh
ERS Genomics
gene editing
CRISPR
Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup
BioPharma Dive
Wed, 02/28/24 - 11:09 am
Ginkgo Bioworks
M&A
Proof Diagnostics
gene editing
Feng Zhang
Gene-editing firm Prime Medicine files $140m public offer
Pharmaphorum
Thu, 02/15/24 - 11:17 am
Prime Medicine
funding
gene editing
Gene editing biotech Metagenomi pulls off nearly $94M IPO
BioPharma Dive
Sun, 02/11/24 - 03:52 pm
IPOs
Metagenomi
gene editing
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia’s CRISPR drug could offer one-shot HAE treatment
Pharmaphorum
Thu, 02/1/24 - 11:26 am
Intellia Therapeutics
HAE
clinical trials
CRISPR
gene editing
NTLA-2002
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
CRISPR Therapeutics
gene editing
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool
Sun, 01/21/24 - 05:01 pm
Editas Medicine
gene editing
CRISPR Therapeutics
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
JPM24, Day 3: Gene editors take the stage to talk business development, germline edits
Fierce Biotech
Wed, 01/10/24 - 11:56 am
JPMHC 2024
gene editing
cell therapy
Gene editing startup Metagenomi files for an IPO
BioPharma Dive
Sun, 01/7/24 - 04:16 pm
Metagenomi
CRISPR
IPOs
gene editing
Intellia to lay off staff, cut some early research
BioPharma Dive
Fri, 01/5/24 - 09:51 am
Intellia Therapeutics
layoffs
gene editing
A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome
BioPharma Dive
Thu, 01/4/24 - 10:10 am
Moonwalk Biosciences
CRISPR
gene editing
funding
Feng Zhang
This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain
Pharma Voice
Tue, 12/19/23 - 10:29 am
Arbor Biotechnologies
gene editing
CRISPR
In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
Stat
Fri, 12/8/23 - 11:36 am
Vertex Pharmaceuticals
FDA
CRISPR
gene editing
Casgevy
sickle cell disease
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Pencils down for Graphite, as gene editing biotech merges into vision-loss-focused Lenz
Fierce Biotech
Wed, 11/15/23 - 11:55 am
Lenz Therapeutics
Graphite Bio
gene editing
reverse merger
vision loss
M&A
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »